Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

26.51
+0.99403.89%
Volume:1.01M
Turnover:26.57M
Market Cap:2.69B
PE:-32.73
High:26.96
Open:24.60
Low:24.60
Close:25.52
52wk High:36.44
52wk Low:13.53
Shares:101.47M
Float Shares:89.94M
Volume Ratio:0.47
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8100
EPS(LYR):-0.8100
ROE:-8.11%
ROA:-18.55%
PB:2.17
PE(LYR):-32.73

Loading ...

CRSP, BEAM, ROKU, SOFI: Cathie Wood Pours $17 Million into Biotech Stocks, Trims Tech Favorites

TIPRANKS
·
Nov 05, 2025

Cathie Wood’s ARK Investment buys 291K shares of Beam Therapeutics today

TIPRANKS
·
Nov 05, 2025

Beam Therapeutics Q3 net loss wider than expected on higher R&D expenses

Reuters
·
Nov 04, 2025

Beam Therapeutics reports third quarter cash position of $1.1 billion

Reuters
·
Nov 04, 2025

Beam Therapeutics Q3 License and Collaboration Revenue USD 9.698 Million

THOMSON REUTERS
·
Nov 04, 2025

Beam Therapeutics Inc - Q3 EPS $-1.10

THOMSON REUTERS
·
Nov 04, 2025

Beam Therapeutics to Present Updated BEAM-101 Sickle Cell Trial Data at ASH 2025

Reuters
·
Nov 03, 2025

Fmr Llc Makes a Strategic Move with Beam Therapeutics Stock!

TIPRANKS
·
Oct 30, 2025

FMR LLC Reports Disposal of Beam Therapeutics Inc. Common Shares

Reuters
·
Oct 30, 2025

Beam Therapeutics’ BEAM-301 Study: A Promising Step in Rare Disease Treatment

TIPRANKS
·
Oct 28, 2025

AI Biotech Stocks Shined. Recursion Up 15%; Beam Up 14%; Tempus Up 7%; Novavax Up 6%; Crispr And Ginkgo Up 4%; Hims Up 2%

Tiger Newspress
·
Oct 20, 2025

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Disc Medicine (IRON)

TIPRANKS
·
Oct 17, 2025

U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity

Reuters
·
Oct 10, 2025

Beam Therapeutics Inc : Jefferies Initiates Coverage With Buy Rating: Target Price $41

THOMSON REUTERS
·
Oct 10, 2025

Beam Therapeutics initiated with a Buy at Jefferies

TIPRANKS
·
Oct 09, 2025

Can Analyst Optimism Around BEAM's Base Editing Progress Reveal Its Edge in Genetic Disease Treatment?

Simply Wall St.
·
Oct 09, 2025

Beam Therapeutics Inc : JP Morgan Cuts Target Price to $46 From $48

THOMSON REUTERS
·
Oct 09, 2025

AI Biotech Stocks Shined. Ginkgo Up 12%; Recursion And Crispr Up 8%; Tempus And Hims & Hers Up 3%

Tiger Newspress
·
Oct 08, 2025

Beam Therapeutics CEO John M. Evans Reports Disposal of Common Shares

Reuters
·
Oct 04, 2025

Cathie Wood’s ARK Investment buys 491K shares of Beam Therapeutics today

TIPRANKS
·
Sep 18, 2025